Aethlon Medical Inc (AEMD) Actualités

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 PR Newswire SAN DIEGO, June 21, 2024 SAN...

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial PR Newswire SAN DIEGO, June 18, 2024 Aethlon Medical Granted...

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies PR Newswire SAN DIEGO, June 3, 2024 Phase 1 Clinical...

Form 8-K - Current report

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness

Form POS AM - Post-Effective amendments for registration statement

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

Aethlon Medical Announces Pricing of $4.7 Million Public Offering PR Newswire SAN DIEGO, May 15, 2024 SAN DIEGO, May 15, 2024 /PRNewswire/...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form 8-K - Current report

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer...

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices PR Newswire SAN DIEGO...